FUKUDA Minoru 福田実

Researcher Number	50388930
Other IDs
Affiliation (Current)	2025: 長崎大学, 医歯薬学総合研究科(医学系), 客員研究員
Affiliation (based on the past Project Information) *help	2022: 長崎大学, 医歯薬学総合研究科(医学系), 客員研究員 2020 – 2021: 長崎大学, 病院(医学系), 准教授 2014 – 2015: 長崎大学, 病院(医学系), 准教授 2013: 長崎大学, 大学病院, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Laboratory medicine
Keywords	Principal Investigator EGFR / VEGF / 免疫チェックポイント / バイオマーカー / 血管内皮増殖因子（VEGF）阻害薬 / 分子標的薬 / 免疫チェックポイント阻害薬 / 血管内皮増殖因子阻害薬 Except Principal Investigator 肺癌化学療法 / 個別化医療 / 個別化治療 / 非小細胞肺癌

Research on cancer drug therapy effect prediction for appropriate use of medical resources and control of medical expensesPrincipal Investigator
- Principal Investigator
  
  FUKUDA Minoru
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Nagasaki University
Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.
- Principal Investigator
  
  NAKAMURA Yoichi
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Laboratory medicine
- Research Institution
  Nagasaki University

All 2021 2015 2014

All Journal Article Presentation

[Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015
- Author(s)
  Mizoguchi K, Nakamura Y, Abe K, Takemoto S, Motoshima K, Ogawara D, Nakatomi K, Fukuda M, Fukuoka J, Kohno, S.
- Journal Title
  
  Cancer Treat Commun
  
  Volume: 4 Pages: 117-120
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460691
[Journal Article] Chemotherapy2015
- Author(s)
  Kasai T, Nakamura Y, Fukuda M, Kitazaki T, Nagashima S, Takatani H, Nakano H, Nakatomi K, Ikeda T, Yamaguchi H, Tsukamoto K, Oka M, Kohno S.
- Journal Title
  
  Phase II study of S-1 for previously untreated elderly patients with advanced non-small cell lung cancer.
  
  Volume: 61 Issue: 2 Pages: 93-98
- DOI
  10.1159/000441486
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K09235, KAKENHI-PROJECT-25460691
[Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014
- Author(s)
  Ikeda T, Fukuda M, Nakamura Y, et al.
- Journal Title
  
  Cancer Chemother Pharmacol
  
  Volume: 74 Issue: 3 Pages: 497-502
- DOI
  10.1007/s00280-014-2527-4
- NAID
  120006986379
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25460691
[Presentation] Ramucirumabの効果予測因子についての研究2021
- Author(s)
  須山隆之、小野沙和奈、本田徳鷹、梅山泰裕、道津洋介、行徳宏、竹本真之輔、山口博之、福田実、迎寛
- Organizer
  第62回日本肺癌学会学術集会号
- Data Source
  KAKENHI-PROJECT-20K07701

1. NAKAMURA Yoichi (20432974)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. NAGASHIMA Seiji (00646672)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. OKA Mikio

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

FUKUDA Minoru 福田実

Research Projects

Research Products

Co-Researchers

Research on cancer drug therapy effect prediction for appropriate use of medical resources and control of medical expensesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015

Author(s)

Journal Title

Data Source

[Journal Article] Chemotherapy2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Ramucirumabの効果予測因子についての研究2021

Author(s)

Organizer

Data Source

FUKUDA Minoru 福田 実

Research Projects

Research Products

Co-Researchers

Research on cancer drug therapy effect prediction for appropriate use of medical resources and control of medical expensesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Analysis of mRNA level of the treatment resistance related proteins in unfixed lung cancer biopsy specimens obtained by core-biopsy.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapy.2015

Author(s)

Journal Title

Data Source

[Journal Article] Chemotherapy2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A phase II study of amrubicin and carboplatin for previously untreated patients with extensive-disease small cell lung cancer2014

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Ramucirumabの効果予測因子についての研究2021

Author(s)

Organizer

Data Source

FUKUDA Minoru 福田実